NCT05389150View on ClinicalTrials.gov

Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

February 5, 2019

Study Completion Date

March 27, 2019

Conditions
Healthy
Interventions
DRUG

Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg

Pregabalin/Tramadol (Laboratorios Silanes S.A. de C.V.), Pharmaceutical Form: Tablet Dosage: 150 mg / 50 mg Administration way: oral

DRUG

Pregabalin 150mg

From Pfizer S.a. de C.V. Pharmaceutical Form: Capsule Dosage: 150 mg Administration way: oral

DRUG

Tramadol 50 mg

From Grünenthal de México, S.A. de C.V. Pharmaceutical Form: Capsule Dosage: 50 mg Administration way: oral

Trial Locations (1)

11000

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY

NCT05389150 - Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects | Biotech Hunter | Biotech Hunter